Free cash flow
Operating cash flow less capital expenditures generated by pharmaceutical and operational activities.
Unit million EUR Industry Pharmaceuticals
The chart
Over time
Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Free cash flow
Global, Q1 2026 to Q2 2026
Every record
All records
2 records · 1 region · 2026
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded | Sanofi | 30 Jul 2026 | 2 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Free cash flow. Retrieved from https://statorigin.org/indicators/free-cash-flow